We serve 6-Carboxy-4-methyl-2-propylbenzimidazole CAS:152628-03-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 6-Carboxy-4-methyl-2-propylbenzimidazole
CAS.NO: 152628-03-0
Synonyms:
4-Methyl-2-propyl-6-benzimidazolecarboxylic acid
4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid
4-Methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid
Molecular Formula: C12H14N2O2
Molecular Weight: 218.25200
Physical and Chemical Properties:
Density: 1.259g / cm3
Boiling point: 491.8ºC at 760mmHg
Melting point: 300ºC
Flash point: 251.2ºC
Refractive index: 1.642
Specification:
Appearance: Light brown powder
Purity:≥99%
Sulfated Ash:NMT 0.3%
Water:NMT 0.5%
Any Single Impurity:NMT 0.25%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Refrigerator (+4°C).Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Telmisartan CAS:144701-48-4
Contact us for information like 6-Carboxy-4-methyl-2-propylbenzimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Methyl-2-propyl-6-benzimidazolecarboxylic acid Use and application,4-Methyl-2-propyl-6-benzimidazolecarboxylic acid technical grade,usp/ep/jp grade.
Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile manufacturer Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.6-Chloropyridazin-3-amine supplier Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.(S)-(+)-3-Hydroxytetrahydrofuran vendor Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).During the deadly SARS pandemic of the early 2000s, another traditional Chinese herbal medicine, Banlangen, made from the root of a flowering woad plant and used to treat the common cold, was sold out in many pharmacies due to a popular but clinically unproven belief that it could help prevent SARS, which is closely related to the Wuhan coronavirus.
